BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8198983)

  • 1. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
    Abdelmoumene N; Schlumberger M; Gardet P; Roche A; Travagli JP; Francese C; Parmentier C
    Br J Cancer; 1994 Jun; 69(6):1141-4. PubMed ID: 8198983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].
    Cupisti K; Simon D; Dotzenrath C; Goretzki PE; Röher HD
    Langenbecks Arch Chir; 1997; 382(6):295-301. PubMed ID: 9498199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of residual lesions and metastases of medullary thyroid cancer].
    Murat A
    Ann Endocrinol (Paris); 1996; 57(1):27-32. PubMed ID: 8734286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical results of reoperations for medullary thyroid carcinoma.
    Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
    Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
    Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
    Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma.
    Machens A; Gimm O; Ukkat J; Sutter T; Dralle H
    Langenbecks Arch Surg; 1999 Jun; 384(3):271-6. PubMed ID: 10437616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
    Medina-Franco H; Herrera MF; López G; Tielve-Campillo M; Sierra M; Lozano-Salazar RR; González O
    Rev Invest Clin; 2001; 53(3):212-7. PubMed ID: 11496707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reoperation for recurrent or persistent medullary thyroid cancer.
    Moley JF; Wells SA; Dilley WG; Tisell LE
    Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization.
    Frank-Raue K; Raue F; Buhr HJ; Baldauf G; Lorenz D; Ziegler R
    Thyroid; 1992; 2(2):113-7. PubMed ID: 1525578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical strategy for the treatment of medullary thyroid carcinoma.
    Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
    Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hypercalcitoninemia in patients with medullary thyroid cancer.
    Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; Giammartino C; Sanguinetti A; d'Ajello M; Ragusa M; Avenia N
    Tumori; 2009; 95(4):484-7. PubMed ID: 19856661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
    Mucha SA; Kunert-Radek J; Pomorski L
    Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified?
    Gimm O; Dralle H
    Surgery; 1997 Dec; 122(6):1124-30; discussion 1130-1. PubMed ID: 9426428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination?
    Machens A; Hauptmann S; Dralle H
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2234-8. PubMed ID: 18364379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer.
    Tung WS; Vesely TM; Moley JF
    Surgery; 1995 Dec; 118(6):1024-9; discussion 1029-30. PubMed ID: 7491518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved results of cervical reoperation for medullary thyroid carcinoma.
    Moley JF; Dilley WG; DeBenedetti MK
    Ann Surg; 1997 Jun; 225(6):734-40; discussion 740-3. PubMed ID: 9230814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markedly elevated serum calcitonin concentrations associated with initial presentation but not the recurrent presentation of medullary thyroid carcinoma.
    Bodenner D; Nalley C; Chien C; Clarke B; Spring PM; Stack BC
    Thyroid; 2010 Aug; 20(8):927-9. PubMed ID: 20677998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.